KPN announces results of its Tender Offer NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT Introduction On 3 February 2026, Koninklijke KPN N.V. (“KPN”) announced offers to holders of its outstanding £ 400m 5.00% notes due 2026 (ISIN: XS0707430947) (of which £250,000,000 in nominal amount currently remains outstanding) and £ 850m 5.75% notes due 2029 (ISIN: XS0451790280) (of which £549,996,000 in nominal amount currently remains outstanding) (together the "N...
KPN announces Indicative Results of its Tender Offer Koninklijke KPN N.V. announces indicative results of its tender offer for its £850,000,000 5.75 per cent. Notes due 2029 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (the United States) OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION W...
WDP's FY25 results were fully in line but the company surprised in already revealing its 2030 targets. We like such long-term visibility combined with very clear targets: €500m of yearly capex that can be auto-financed, delivering a +6% CAGR. WDP now has pan-European ambitions and aims to establish a presence in Italy and Spain. While the company has not delivered on its entrance into Germany, we think that opening itself to new countries is the right ambition to have at this stage. The plan loo...
KPN reports on progress of € 250m share buyback KPN has repurchased 1,000,000 KPN ordinary shares in the period from 2 February to 6 February 2026. The shares were repurchased at an average price of € 4.34 per share for a total consideration of € 4.3m. These repurchases are part of the € 250m share buyback started on 29 January 2026 and reflect KPN's commitment to structurally return additional capital to its shareholders. The total number of ordinary shares repurchased until 6 February 2026 is 1,400,000 for a total consideration of € 6.0m. Aggregated transaction details of the share buyb...
After today's changes (ASMi out, UCB in), we maintain a balanced approach in our Dynamic Top Pick List, with a particular emphasis on value stocks that have been overlooked. Our defensive holdings are overweight, including real estate, which stands to benefit from lower interest rates. We remove ASMi from our Dynamic Top Pick List as the recent share price performance has driven the valuation meaningfully ahead of fundamentals. Since early December, FY27 diluted EPS expectations have risen by a...
Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 Daix (France), New York (United States), February 4, 2025 – (Euronext Paris and NASDAQ: ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced that CEO Andrew Obenshain has been invited to participate in a fireside chat at the upcoming Guggenheim Emerging Outlook: Biotech Summit 2026. The conference is being held February 11-12, 2026 at the Lotte New Yor...
Inventiva présentera au Guggenheim Emerging Outlook : Biotech Summit 2026 Daix (France), New York (États-Unis), le 4 février 2026 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la stéatohépatite associée à un dysfonctionnement métabolique (« MASH »), a annoncé aujourd’hui que son Directeur général, Andrew Obenshain, a été invité à participer à un « fireside chat » lors du prochain Guggenheim Emerging Outlook: Biotech Summit 2026. La conférence se tiendra le...
KPN successfully issues € 500m senior bond NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT Today, Koninklijke KPN N.V. (“KPN”) has successfully issued a € 500m senior unsecured bond with a 3.500% coupon maturing on 12 May 2034 (the “Bonds”). The new Bonds increase the average maturity of KPN’s outstanding bonds and have been placed with a broad range of institutional investors. Earlier today, KPN announced an offer to repurchase part of KPN’s outstanding GB...
KPN announces Eurobond and Tender Offer Today, Koninklijke KPN N.V. (“KPN”) announces its intention to issue a EUR 500m (expected) size Eurobond under its Global Medium Term Note programme. The proceeds from the new bond offering will be used to refinance existing indebtedness and for general corporate purposes. Simultaneously, KPN announces an offer to repurchase any and all of its GBP 400m 5.00% notes due 2026 (ISIN: XS0707430947) of which GBP 250m is outstanding and up to GBP 300m of its GBP 850m 5.75% notes due 2029 (ISIN: XS0451790280) of which GBP 550m is outstanding (the “Offers”). ...
KPN reports on progress of € 250m share buyback KPN has repurchased 400,000 KPN ordinary shares in the period from 29 January to 30 January 2026. The shares were repurchased at an average price of € 4.09 per share for a total consideration of € 1.6m. These repurchases are part of the € 250m share buyback started on 29 January 2026 and reflect KPN's commitment to structurally return additional capital to its shareholders. The total number of ordinary shares repurchased until 30 January 2026 is 400,000 for a total consideration of € 1.6m. Aggregated transaction details of the share buyback ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.